Cassava Sciences (SAVA) announced the retirement of James Kupiec, chief medical officer, effective May 9. The company also appointed Jack Moore ...

today announced the retirement of James W. Kupiec, MD, Chief Medical Officer, effective May 9, 2025. The Company also appointed Jack Moore, PhD, as Senior Vice President, Clinical Development ...

Cassava Sciences (NASDAQ:SAVA) announced on Monday the retirement of James W. Kupiec, Chief Medical Officer, effective May 9, ...

James W. Kupiec, MD, effective May 9, 2025. According to InvestingPro data, the company maintains a strong liquidity position with a current ratio of 11.6, though it faces challenges with rapid ...

Cassava Sciences said its chief medical officer, Dr. James Kupiec, is retiring, effective May 9. Under Kupiec, the clinical-stage biotechnology company completed a clinical trial program in ...